FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/072558 [Registered on: 16/08/2024] Trial Registered Prospectively
Last Modified On: 13/10/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   prospective 
Study Design  Other 
Public Title of Study   Predictors of ICU outcome with Lactate Concentration, Base Excess and Alactic Base Excess (ABE) as in patients with sepsis and septic shock  
Scientific Title of Study   Lactate Concentration, Base Excess and Alactic Base Excess (ABE) as predictors of ICU outcome in patients with sepsis and septic shock :An observational study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Afzal Azim 
Designation  Professor Critical Care Medicine 
Affiliation  Sanjay Gandhi Poatgraduate Institute of Medical Sciences, Raebareli Road, Lucknow 
Address  Department of Critical Care Medicine,Sanjay Gandhi Poatgraduate Institute of Medical Sciences, Raebareli Road, Lucknow

Lucknow
UTTAR PRADESH
226014
India 
Phone  9984988393  
Fax    
Email  draazim2002@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ashish kumar sharma 
Designation  Senior resident 
Affiliation  DM senior resident 
Address  Department of Critical Care Medicine,Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow

Lucknow
UTTAR PRADESH
226014
India 
Phone  8989843686  
Fax    
Email  dr.aaashishsharma@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Afzal Azim 
Designation  Professor Critical Care Medicine 
Affiliation  Sanjay Gandhi Poatgraduate Institute of Medical Sciences, Raebareli Road, Lucknow 
Address  Department of Critical Care Medicine,Sanjay Gandhi Poatgraduate Institute of Medical Sciences, Raebareli Road, Lucknow

Lucknow
UTTAR PRADESH
226014
India 
Phone  9984988393  
Fax    
Email  draazim2002@gmail.com  
 
Source of Monetary or Material Support  
Not applicable 
 
Primary Sponsor  
Name  Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow 
Address  Department of critical Care Medicine Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow-226014 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR Afzal Azim  SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES LUCKNOW  1st Floor, F block, DEPARTMENT OF CRITICAL CARE MEDICINE, SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES LUCKNOW, 226014
Lucknow
UTTAR PRADESH 
9984988393

draazim2002@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE, SGPGIMS, LUCKNOW  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E874||Mixed disorder of acid-base balance,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  Age more than 18 years
Patients with sepsis or septic shock
Acute kidney injury stage I and II
 
 
ExclusionCriteria 
Details  AKI stage III
AKI on RRT
CKD patients eGFR less than 60
Patients on diuretic therapy at admission
Post renal transplant patients
Expected stay in ICU less than 72 hours
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To investigate BE, lactate, and ABE as a predictors of ICU outcome  4 WEEKS 
 
Secondary Outcome  
Outcome  TimePoints 
Duration and dose of vasopressors use in sepsis and septic shock patients
Days of vasopressor use
Stage and progression of AKI at admission and during ICU stay
Need of RRT during ICU stay
Total days of Mechanical ventilation
Total length of ICU stay / Total days of hospitalization.
 
28 days 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   26/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Yet Recruiting 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Project details- Shock is a life threatening hemodynamic emergency leading to hypo perfusion of tissue and cause severe metabolic changes at cellular level. Acid base imbalance in shock is due to low oxygen delivery to tissue, high oxygen consumption or inadequate utilization which leads to various metabolic derangements with or without hyperlactataemia. Hyperlactetemia may be accompanied by metabolic acidosis or as a separate entity not affecting the acid-base status. In 2019, Gattinoni et al introduced a new term alactic base excess (ABE) to differentiate between metabolic acidosis caused by lactate accumulation and non lactate fixed acids (unmeasured fixed ions) not eliminated by lungs, eg sulphates and phosphates. Conceptually ABE is the sum of negative values of base excess and lactate. The effect of ABE in septic patients was studied by Gattinoni at el and they concluded that it possibly reflects the impact of renal dysfunction on plasma lactate concentration and acid base balance. They also found that increased plasma lactate indicates sepsis severity and that ABE can be used to estimate renal capacity to handle acid base balance. “Alactic base excess” (ABE) recently introduced by Gattinoni et al is the sum of base excess and lactate (ABE= BE+L). ABE represents the number/concentration of abnormal strong acids other than lactate in plasma. Nevertheless, the predictive value of ABE has not yet been investigated in different septic shock patients and needs validation in ICU settings.so in this observational study we aim to investigate the further potential prognostic value of ABE and its contributors, i.e., lactate concentration and BE to predicting 28 days mortality in shock patients admitted in our ICU. Simultaneously we will examine duration and dose of vasopressors use in sepsis and septic shock patients,days of vasopressor use,stage and progression of AKI at admission and during ICU stay,need of RRT during ICU stay,total days of Mechanical ventilation,total length of ICU stay / total days of hospitalization as seconary objectives.
 
Close